(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:732751 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of NR4A1 mRNA CTD PMID:22079256 (R)-pantothenic acid multiple interactions EXP 6480464 [Glycerol co-treated with Succinic Acid co-treated with Glucose-6-Phosphate co-treated with Pantothenic Acid co-treated with Niacinamide] results in increased expression of NR4A1 mRNA CTD PMID:20505214 (S)-amphetamine increases expression EXP 6480464 Dextroamphetamine results in increased expression of NR4A1 mRNA CTD PMID:19194377 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of NR4A1 mRNA CTD PMID:21955143 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of NR4A1 mRNA CTD PMID:17456735 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane increases expression EXP 6480464 2 more ... CTD PMID:20826375 1,2,4-trimethylbenzene increases expression ISO RGD:620029 6480464 pseudocumene results in increased expression of NR4A1 protein CTD PMID:17337753 1,2-dimethylhydrazine multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NR4A1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of NR4A1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of NR4A1 mRNA CTD PMID:17555576 17beta-estradiol decreases expression ISO RGD:732751 6480464 Estradiol results in decreased expression of NR4A1 mRNA CTD PMID:16514628 17beta-estradiol increases expression ISO RGD:732751 6480464 Estradiol results in increased expression of NR4A1 mRNA CTD PMID:31614463 17beta-estradiol multiple interactions ISO RGD:732751 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of NR4A1 mRNA CTD PMID:30165855 17beta-estradiol multiple interactions EXP 6480464 ESR1 protein promotes the reaction [Estradiol results in increased expression of NR4A1 mRNA] CTD PMID:20667977 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of NR4A1 mRNA CTD PMID:20667977 more ... 17beta-estradiol decreases expression ISO RGD:620029 6480464 Estradiol results in decreased expression of NR4A1 mRNA CTD PMID:20068009 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of NR4A1 mRNA CTD PMID:15598610 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one multiple interactions ISO RGD:732751 6480464 Dapsone analog inhibits the reaction [Metribolone results in increased expression of NR4A1 mRNA] CTD PMID:21440447 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO RGD:732751 6480464 Metribolone results in increased expression of NR4A1 mRNA CTD PMID:21440447 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:732751 6480464 Dihydrotestosterone results in increased expression of NR4A1 mRNA CTD PMID:29581250 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:732751 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of NR4A1 mRNA CTD PMID:16962184 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:620029 6480464 Tetrachlorodibenzodioxin results in increased expression of NR4A1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:620029 6480464 Tetrachlorodibenzodioxin results in decreased expression of NR4A1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NR4A1 mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732751 6480464 Tetrachlorodibenzodioxin results in increased expression of NR4A1 mRNA CTD PMID:26238291 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO RGD:620029 6480464 2 more ... CTD PMID:32109520 2-butoxyethanol increases expression EXP 6480464 n-butoxyethanol results in increased expression of NR4A1 mRNA CTD PMID:19812364 2-hydroxypropanoic acid increases expression ISO RGD:732751 6480464 Lactic Acid results in increased expression of NR4A1 mRNA CTD PMID:30851411 2-methoxyethanol increases expression ISO RGD:620029 6480464 methyl cellosolve results in increased expression of NR4A1 mRNA CTD PMID:19643169 3,3',4,4',5-pentachlorobiphenyl multiple interactions EXP 6480464 3 more ... CTD PMID:30312631 3,3',5-triiodo-L-thyronine multiple interactions EXP 6480464 2 more ... CTD PMID:21726595 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of NR4A1 mRNA CTD PMID:20188158 3,5-dichloro-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-6-methoxybenzamide affects response to substance EXP 6480464 NR4A1 affects the susceptibility to Raclopride CTD PMID:14603264 3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione multiple interactions EXP 6480464 bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NR4A1 protein] CTD PMID:19282384 3-methylcholanthrene decreases expression EXP 6480464 Methylcholanthrene results in decreased expression of NR4A1 mRNA CTD PMID:20713471 3-Nitrobenzanthrone increases expression ISO RGD:732751 6480464 3-nitrobenzanthrone results in increased expression of NR4A1 mRNA CTD PMID:34036453 4,4'-sulfonyldiphenol increases expression ISO RGD:620029 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of NR4A1 mRNA CTD PMID:26186136 4,4'-sulfonyldiphenol affects methylation EXP 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of NR4A1 gene CTD PMID:31683443 4,4'-sulfonyldiphenol multiple interactions ISO RGD:620029 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NR4A1 mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol decreases methylation ISO RGD:732751 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of NR4A1 gene CTD PMID:31601247 4,5,6,7-TETRABROMOBENZOTRIAZOLE multiple interactions EXP 6480464 4 more ... CTD PMID:26301327 4-hydroxynon-2-enal decreases expression EXP 6480464 4-hydroxy-2-nonenal results in decreased expression of NR4A1 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide multiple interactions ISO RGD:732751 6480464 [Fenretinide co-treated with scriptaid] affects the localization of NR4A1 protein more ... CTD PMID:19912993 , PMID:21319187 4-hydroxyphenyl retinamide affects response to substance ISO RGD:732751 6480464 NR4A1 protein affects the susceptibility to Fenretinide CTD PMID:19912993 4-hydroxyphenyl retinamide increases expression ISO RGD:732751 6480464 Fenretinide results in increased expression of NR4A1 mRNA, Fenretinide results in increased expression of NR4A1 protein CTD PMID:19912993 , PMID:21319187 4-hydroxyphenyl retinamide affects localization ISO RGD:732751 6480464 Fenretinide affects the localization of NR4A1 protein CTD PMID:21319187 5-azacytidine multiple interactions ISO RGD:732751 6480464 [metacept-1 co-treated with Azacitidine] results in increased expression of NR4A1 CTD PMID:19148494 5-fluorouracil affects expression ISO RGD:732751 6480464 Fluorouracil affects the expression of NR4A1 mRNA CTD PMID:15205334 , PMID:16557594 7,12-dimethyltetraphene multiple interactions EXP 6480464 [CYP1B1 protein affects the susceptibility to 9 more ... CTD PMID:27891153 8-Br-cAMP increases expression EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR4A1 protein CTD PMID:21726595 8-Br-cAMP increases expression ISO RGD:732751 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR4A1 mRNA CTD PMID:22079614 8-OH-DPAT multiple interactions ISO RGD:620029 6480464 8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Haloperidol results in increased expression of NR4A1 mRNA] CTD PMID:19695244 acetaldehyde increases expression ISO RGD:732751 6480464 Acetaldehyde results in increased expression of NR4A1 mRNA CTD PMID:23416264 acetamide increases expression ISO RGD:620029 6480464 acetamide results in increased expression of NR4A1 mRNA CTD PMID:31881176 acrolein increases expression ISO RGD:732751 6480464 Acrolein results in increased expression of NR4A1 mRNA, Acrolein results in increased expression of NR4A1 protein CTD PMID:20015449 acrylamide decreases expression ISO RGD:620029 6480464 Acrylamide results in decreased expression of NR4A1 mRNA CTD PMID:22197712 , PMID:28959563 acrylamide increases expression ISO RGD:732751 6480464 Acrylamide results in increased expression of NR4A1 mRNA CTD PMID:32763439 afimoxifene increases expression ISO RGD:732751 6480464 afimoxifene results in increased expression of NR4A1 mRNA CTD PMID:16514628 aflatoxin B1 increases expression ISO RGD:620029 6480464 Aflatoxin B1 results in increased expression of NR4A1 mRNA CTD PMID:25378103 , PMID:33354967 aflatoxin B1 decreases methylation ISO RGD:732751 6480464 Aflatoxin B1 results in decreased methylation of NR4A1 exon CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO RGD:732751 6480464 aflatoxin B2 results in increased methylation of NR4A1 intron CTD PMID:30157460 all-trans-retinoic acid multiple interactions ISO RGD:732751 6480464 leptomycin B inhibits the reaction [Tretinoin affects the localization of [NR4A1 protein binds to RXRA protein]] more ... CTD PMID:10919358 , PMID:14592536 all-trans-retinoic acid decreases expression ISO RGD:732751 6480464 Tretinoin results in decreased expression of NR4A1 mRNA CTD PMID:23830798 alpha-amanitin multiple interactions ISO RGD:620029 6480464 Alpha-Amanitin inhibits the reaction [LHB protein results in increased expression of NR4A1 mRNA] CTD PMID:11416027 ammonium chloride affects expression ISO RGD:620029 6480464 Ammonium Chloride affects the expression of NR4A1 mRNA CTD PMID:16483693 amphetamine increases expression ISO RGD:620029 6480464 Amphetamine results in increased expression of NR4A1 mRNA CTD PMID:12638131 , PMID:14622910 amphetamine decreases expression ISO RGD:620029 6480464 Amphetamine results in decreased expression of NR4A1 mRNA CTD PMID:15183010 , PMID:30779732 amphetamine multiple interactions ISO RGD:620029 6480464 Amphetamine promotes the reaction [Ibotenic Acid results in decreased expression of NR4A1 mRNA] CTD PMID:14622910 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone promotes the reaction [Ozone results in increased expression of NR4A1 mRNA] CTD PMID:17460151 aristolochic acid A increases expression ISO RGD:732751 6480464 aristolochic acid I results in increased expression of NR4A1 mRNA CTD PMID:33212167 arsane decreases expression EXP 6480464 Arsenic results in decreased expression of NR4A1 mRNA CTD PMID:19654921 arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of NR4A1 mRNA CTD PMID:19654921 arsenite(3-) multiple interactions EXP 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of NR4A1 mRNA CTD PMID:15894712 arsenite(3-) decreases expression EXP 6480464 arsenite results in decreased expression of NR4A1 mRNA CTD PMID:15894712 arsenous acid decreases expression ISO RGD:732751 6480464 Arsenic Trioxide results in decreased expression of NR4A1 mRNA CTD PMID:20458559 ATP increases expression ISO RGD:620029 6480464 Adenosine Triphosphate results in increased expression of NR4A1 mRNA CTD PMID:10723097 atrazine increases expression ISO RGD:732751 6480464 Atrazine results in increased expression of NR4A1 mRNA CTD PMID:18461179 atrazine decreases expression ISO RGD:732751 6480464 Atrazine results in decreased expression of NR4A1 mRNA CTD PMID:34146662 benzene decreases expression EXP 6480464 Benzene results in decreased expression of NR4A1 mRNA CTD PMID:15120971 , PMID:15122651 benzene increases expression EXP 6480464 Benzene results in increased expression of NR4A1 mRNA CTD PMID:34624356 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of NR4A1 mRNA CTD PMID:15894712 , PMID:20713471 benzo[a]pyrene affects methylation ISO RGD:732751 6480464 Benzo(a)pyrene affects the methylation of NR4A1 intron CTD PMID:30157460 benzo[a]pyrene decreases expression ISO RGD:732751 6480464 Benzo(a)pyrene results in decreased expression of NR4A1 mRNA CTD PMID:22178795 benzo[a]pyrene increases expression ISO RGD:732751 6480464 Benzo(a)pyrene results in increased expression of NR4A1 mRNA CTD PMID:22316170 , PMID:32234424 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of NR4A1 mRNA CTD PMID:21569818 benzo[a]pyrene multiple interactions EXP 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of NR4A1 mRNA CTD PMID:15894712 benzo[a]pyrene diol epoxide I increases expression ISO RGD:732751 6480464 7 more ... CTD PMID:26238291 bis(2-ethylhexyl) phthalate increases expression ISO RGD:620029 6480464 Diethylhexyl Phthalate results in increased expression of NR4A1 mRNA CTD PMID:15728792 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of NR4A1 mRNA CTD PMID:28085963 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of NR4A1 mRNA CTD PMID:32522588 bisphenol A affects expression ISO RGD:732751 6480464 bisphenol A affects the expression of NR4A1 mRNA CTD PMID:20170705 bisphenol A multiple interactions ISO RGD:732751 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of NR4A1 gene CTD PMID:31601247 bisphenol A decreases methylation ISO RGD:732751 6480464 bisphenol A results in decreased methylation of NR4A1 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:620029 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NR4A1 mRNA more ... CTD PMID:33582411 , PMID:36041667 bisphenol A decreases expression ISO RGD:620029 6480464 bisphenol A results in decreased expression of NR4A1 mRNA, bisphenol A results in decreased expression of NR4A1 protein CTD PMID:33582411 , PMID:34947998 bisphenol A increases methylation ISO RGD:620029 6480464 bisphenol A results in increased methylation of NR4A1 gene CTD PMID:28505145 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of NR4A1 promoter CTD PMID:27312807 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of NR4A1 promoter CTD PMID:27334623 bisphenol A decreases expression ISO RGD:732751 6480464 bisphenol A results in decreased expression of NR4A1 mRNA CTD PMID:27685785 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of NR4A1 mRNA CTD PMID:25594700 , PMID:33221593 bisphenol A affects expression ISO RGD:620029 6480464 bisphenol A affects the expression of NR4A1 mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bisphenol A results in increased expression of NR4A1 mRNA] more ... CTD PMID:12021184 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NR4A1 mRNA CTD PMID:12021184 , PMID:20826375 Bisphenol A diglycidyl ether multiple interactions EXP 6480464 NR4A1 protein promotes the reaction [2, 2-bis(4-glycidyloxyphenyl)propane affects the abundance of Progesterone] CTD PMID:18525235 Bisphenol A diglycidyl ether increases expression EXP 6480464 2 more ... CTD PMID:18525235 bisphenol F increases expression ISO RGD:620029 6480464 4, 4'-bisphenol F results in increased expression of NR4A1 mRNA CTD PMID:26186136 bisphenol F multiple interactions ISO RGD:620029 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of NR4A1 mRNA CTD PMID:36041667 bucladesine multiple interactions EXP 6480464 NR0B1 protein inhibits the reaction [Bucladesine results in increased expression of NR4A1 protein] more ... CTD PMID:18787026 , PMID:19282384 bucladesine increases expression EXP 6480464 Bucladesine results in increased expression of NR4A1 protein CTD PMID:18787026 , PMID:19282384 buta-1,3-diene decreases expression EXP 6480464 1, 3-butadiene results in decreased expression of NR4A1 mRNA CTD PMID:29038090 butanal increases expression ISO RGD:732751 6480464 butyraldehyde results in increased expression of NR4A1 mRNA CTD PMID:26079696 C.I. Natural Red 20 multiple interactions EXP 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of NR4A1 mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A1 mRNA] CTD PMID:25451590 cadmium atom multiple interactions ISO RGD:732751 6480464 NR4A1 mutant form inhibits the reaction [Cadmium results in increased expression of BAX mRNA] CTD PMID:15016657 cadmium atom increases expression ISO RGD:732751 6480464 Cadmium results in increased expression of NR4A1 mRNA CTD PMID:22562489 cadmium dichloride increases expression ISO RGD:620029 6480464 Cadmium Chloride results in increased expression of NR4A1 mRNA CTD PMID:19010381 , PMID:33453195 cadmium sulfate increases expression ISO RGD:732751 6480464 cadmium sulfate results in increased expression of NR4A1 mRNA CTD PMID:21783983 Calcimycin increases expression EXP 6480464 Calcimycin results in increased expression of NR4A1 mRNA CTD PMID:25451590 Calcimycin multiple interactions EXP 6480464 NR4A1 mRNA promotes the reaction [Calcimycin results in increased expression of TNF mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A1 mRNA] CTD PMID:25451590 calcitriol multiple interactions ISO RGD:732751 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of NR4A1 mRNA CTD PMID:21592394 calcitriol increases expression ISO RGD:732751 6480464 Calcitriol results in increased expression of NR4A1 mRNA CTD PMID:21592394 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon results in decreased expression of NR4A1 mRNA CTD PMID:25554681 , PMID:25620056 carbonyl sulfide affects expression ISO RGD:620029 6480464 carbonyl sulfide affects the expression of NR4A1 mRNA CTD PMID:19395590 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of NR4A1 mRNA CTD PMID:23125180 chlorpyrifos decreases expression ISO RGD:620029 6480464 Chlorpyrifos results in decreased expression of NR4A1 mRNA CTD PMID:18668222 Chorionic gonadotropin increases expression ISO RGD:620029 6480464 Chorionic Gonadotropin results in increased expression of NR4A1 mRNA CTD PMID:11416027 Chorionic gonadotropin multiple interactions ISO RGD:620029 6480464 Chorionic Gonadotropin inhibits the reaction [Pentobarbital results in decreased expression of NR4A1 mRNA] CTD PMID:11416027 cisplatin affects response to substance ISO RGD:732751 6480464 NR4A1 protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin multiple interactions ISO RGD:732751 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of NR4A1 mRNA CTD PMID:27392435 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of NR4A1 mRNA CTD PMID:24280081 cisplatin increases expression ISO RGD:732751 6480464 Cisplatin results in increased expression of NR4A1 mRNA CTD PMID:24280081 , PMID:27392435 clozapine increases expression ISO RGD:620029 6480464 Clozapine results in increased expression of NR4A1 mRNA CTD PMID:10987852 , PMID:19695244 clozapine decreases expression ISO RGD:620029 6480464 Clozapine results in decreased expression of NR4A1 mRNA CTD PMID:10987852 , PMID:11564422 cocaine increases expression ISO RGD:620029 6480464 Cocaine results in increased expression of NR4A1 mRNA CTD PMID:12117546 cocaine affects expression ISO RGD:620029 6480464 Cocaine affects the expression of NR4A1 mRNA CTD PMID:12358776 more ... colforsin daropate hydrochloride multiple interactions EXP 6480464 [Colforsin co-treated with deoxynivalenol] results in increased expression of NR4A1 mRNA more ... CTD PMID:23183170 , PMID:26783879 colforsin daropate hydrochloride multiple interactions ISO RGD:732751 6480464 NR4A1 protein inhibits the reaction [Colforsin results in increased expression of CYP19A1 mRNA] CTD PMID:19822197 colforsin daropate hydrochloride increases expression EXP 6480464 Colforsin results in increased expression of NR4A1 mRNA, Colforsin results in increased expression of NR4A1 protein CTD PMID:23183170 , PMID:8164692 copper atom increases expression ISO RGD:732751 6480464 Copper results in increased expression of NR4A1 mRNA CTD PMID:19747488 copper atom multiple interactions ISO RGD:732751 6480464 [Chelating Agents binds to Copper] which results in decreased expression of NR4A1 mRNA CTD PMID:30911355 copper(0) increases expression ISO RGD:732751 6480464 Copper results in increased expression of NR4A1 mRNA CTD PMID:19747488 copper(0) multiple interactions ISO RGD:732751 6480464 [Chelating Agents binds to Copper] which results in decreased expression of NR4A1 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO RGD:732751 6480464 Copper Sulfate results in increased expression of NR4A1 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:732751 6480464 Asbestos, Crocidolite results in increased expression of NR4A1 mRNA CTD PMID:18687144 crocidolite asbestos affects expression ISO RGD:732751 6480464 Asbestos, Crocidolite affects the expression of NR4A1 mRNA CTD PMID:25757056 CU-O LINKAGE increases expression ISO RGD:732751 6480464 cupric oxide results in increased expression of NR4A1 mRNA, cupric oxide results in increased expression of NR4A1 protein CTD PMID:22077320 CU-O LINKAGE decreases response to substance ISO RGD:732751 6480464 NR4A1 protein results in decreased susceptibility to cupric oxide CTD PMID:22077320 Cuprizon decreases expression ISO RGD:620029 6480464 Cuprizone results in decreased expression of NR4A1 mRNA CTD PMID:26577399 cycloheximide multiple interactions ISO RGD:620029 6480464 Cycloheximide promotes the reaction [LHB protein results in increased expression of NR4A1 mRNA] CTD PMID:11416027 cyclosporin A multiple interactions ISO RGD:732751 6480464 Cyclosporine inhibits the reaction [cadmium acetate results in increased expression of NR4A1 protein] CTD PMID:15016657 cyclosporin A multiple interactions EXP 6480464 Cyclosporine inhibits the reaction [Antigen-Antibody Complex results in increased expression of NR4A1 mRNA] CTD PMID:25451590 cylindrospermopsin increases expression ISO RGD:732751 6480464 cylindrospermopsin results in increased expression of NR4A1 mRNA CTD PMID:24921660 D-glucopyranose 6-phosphate multiple interactions EXP 6480464 [Glycerol co-treated with Succinic Acid co-treated with Glucose-6-Phosphate co-treated with Pantothenic Acid co-treated with Niacinamide] results in increased expression of NR4A1 mRNA CTD PMID:20505214 D-penicillamine increases expression ISO RGD:620029 6480464 Penicillamine results in increased expression of NR4A1 mRNA CTD PMID:19575532 daidzein multiple interactions ISO RGD:732751 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of NR4A1 mRNA CTD PMID:27424125 daidzein 7-O-beta-D-glucoside multiple interactions ISO RGD:732751 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of NR4A1 mRNA CTD PMID:27424125 dapsone multiple interactions ISO RGD:732751 6480464 Dapsone analog inhibits the reaction [Metribolone results in increased expression of NR4A1 mRNA] CTD PMID:21440447 DDE increases activity ISO RGD:732751 6480464 Dichlorodiphenyl Dichloroethylene results in increased activity of NR4A1 protein CTD PMID:27589886 deoxynivalenol multiple interactions EXP 6480464 [Colforsin co-treated with deoxynivalenol] results in increased expression of NR4A1 mRNA CTD PMID:26783879 deoxynivalenol increases expression EXP 6480464 deoxynivalenol results in increased expression of NR4A1 mRNA CTD PMID:15371230 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [Pentylenetetrazole results in increased expression of NR4A1 mRNA] CTD PMID:8164692 dexamethasone affects localization ISO RGD:620029 6480464 Dexamethasone affects the localization of NR4A1 protein CTD PMID:16403471 diarsenic trioxide decreases expression ISO RGD:732751 6480464 Arsenic Trioxide results in decreased expression of NR4A1 mRNA CTD PMID:20458559 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of NR4A1 mRNA CTD PMID:17361019 , PMID:21266533 dibutyl phthalate increases expression ISO RGD:620029 6480464 Dibutyl Phthalate results in increased expression of NR4A1 mRNA CTD PMID:21266533 , PMID:21745491 dichlorine decreases expression ISO RGD:620029 6480464 Chlorine results in decreased expression of NR4A1 mRNA CTD PMID:18636392 dichlorine multiple interactions ISO RGD:620029 6480464 [Ozone co-treated with Chlorine] affects the expression of NR4A1 mRNA CTD PMID:18636392 dicrotophos increases expression ISO RGD:732751 6480464 dicrotophos results in increased expression of NR4A1 mRNA CTD PMID:28302478 dieldrin increases expression ISO RGD:732751 6480464 Dieldrin results in increased expression of NR4A1 mRNA CTD PMID:31068361 dimethylselenide multiple interactions ISO RGD:732751 6480464 [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of NR4A1AS mRNA] which results in increased expression of NR4A1 mRNA CTD PMID:33656867 dinophysistoxin 1 increases expression ISO RGD:732751 6480464 dinophysistoxin 1 results in increased expression of NR4A1 mRNA CTD PMID:28939011 dipentyl phthalate increases expression ISO RGD:620029 6480464 di-n-pentyl phthalate results in increased expression of NR4A1 mRNA CTD PMID:15728792 doxorubicin affects expression ISO RGD:732751 6480464 Doxorubicin affects the expression of NR4A1 mRNA CTD PMID:15205334 doxorubicin increases expression ISO RGD:620029 6480464 Doxorubicin results in increased expression of NR4A1 mRNA CTD PMID:32289291 doxorubicin decreases expression ISO RGD:732751 6480464 Doxorubicin results in decreased expression of NR4A1 mRNA CTD PMID:29803840 doxorubicin multiple interactions EXP 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of NR4A1 mRNA CTD PMID:21040762 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of NR4A1 mRNA CTD PMID:21040762 doxorubicin decreases response to substance ISO RGD:732751 6480464 NR4A1 mRNA results in decreased susceptibility to Doxorubicin CTD PMID:16322897 endosulfan increases expression ISO RGD:620029 6480464 Endosulfan results in increased expression of NR4A1 mRNA CTD PMID:29391264 epoxiconazole affects expression EXP 6480464 epoxiconazole affects the expression of NR4A1 mRNA CTD PMID:35436446 ethanol increases expression EXP 6480464 Ethanol results in increased expression of NR4A1 mRNA CTD PMID:21955143 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of NR4A1 mRNA CTD PMID:29018328 febuxostat increases expression ISO RGD:732751 6480464 Febuxostat results in increased expression of NR4A1 mRNA CTD PMID:35866629 fenofibrate multiple interactions ISO RGD:732751 6480464 Fenofibrate inhibits the reaction [NR4A1 protein results in increased expression of SERPINE1 mRNA], NR0B2 protein promotes the reaction [Fenofibrate inhibits the reaction [NR4A1 protein results in increased expression of SERPINE1 mRNA]] CTD PMID:19593819 fenthion increases expression ISO RGD:732751 6480464 Fenthion results in increased expression of NR4A1 CTD PMID:21538558 fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of NR4A1 mRNA, SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of NR4A1 mRNA] CTD PMID:28329830 folic acid multiple interactions EXP 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of NR4A1 mRNA CTD PMID:22206623 formaldehyde increases expression ISO RGD:732751 6480464 Formaldehyde results in increased expression of NR4A1 mRNA CTD PMID:28937961 fulvestrant increases expression ISO RGD:732751 6480464 fulvestrant results in increased expression of NR4A1 mRNA CTD PMID:16514628 fulvestrant multiple interactions ISO RGD:732751 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of NR4A1 gene CTD PMID:31601247 furan increases methylation ISO RGD:620029 6480464 furan results in increased methylation of NR4A1 gene CTD PMID:22079235 genistein decreases expression ISO RGD:732751 6480464 Genistein results in decreased expression of NR4A1 mRNA CTD PMID:16705744 genistein multiple interactions ISO RGD:732751 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of NR4A1 mRNA CTD PMID:27424125 genistein increases expression ISO RGD:732751 6480464 Genistein results in increased expression of NR4A1 mRNA CTD PMID:23019147 genistein 7-O-beta-D-glucoside multiple interactions ISO RGD:732751 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of NR4A1 mRNA CTD PMID:27424125 gentamycin increases expression ISO RGD:620029 6480464 Gentamicins results in increased expression of NR4A1 mRNA CTD PMID:33387578 glutathione multiple interactions ISO RGD:732751 6480464 Glutathione inhibits the reaction [NR4A1 protein affects the cleavage of ATF4 protein] more ... CTD PMID:24515801 , PMID:26035713 glycerol multiple interactions EXP 6480464 [Glycerol co-treated with Succinic Acid co-treated with Glucose-6-Phosphate co-treated with Pantothenic Acid co-treated with Niacinamide] results in increased expression of NR4A1 mRNA CTD PMID:20505214 glycidol decreases expression ISO RGD:620029 6480464 glycidol results in decreased expression of NR4A1 mRNA CTD PMID:24915197 glycitein multiple interactions ISO RGD:732751 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of NR4A1 mRNA CTD PMID:27424125 glycitin multiple interactions ISO RGD:732751 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in decreased expression of NR4A1 mRNA CTD PMID:27424125 gold atom multiple interactions EXP 6480464 [Gold co-treated with Polyethylene Glycols] results in increased expression of NR4A1 mRNA CTD PMID:19695318 gold(0) multiple interactions EXP 6480464 [Gold co-treated with Polyethylene Glycols] results in increased expression of NR4A1 mRNA CTD PMID:19695318 haloperidol affects response to substance EXP 6480464 NR4A1 affects the susceptibility to Haloperidol CTD PMID:14603264 haloperidol multiple interactions ISO RGD:620029 6480464 8-Hydroxy-2-(di-n-propylamino)tetralin inhibits the reaction [Haloperidol results in increased expression of NR4A1 mRNA] CTD PMID:19695244 haloperidol increases expression ISO RGD:620029 6480464 Haloperidol results in increased expression of NR4A1 mRNA CTD PMID:10987852 , PMID:19695244 haloperidol decreases expression ISO RGD:620029 6480464 Haloperidol results in decreased expression of NR4A1 mRNA CTD PMID:11564422 hydrogen peroxide affects expression ISO RGD:732751 6480464 Hydrogen Peroxide affects the expression of NR4A1 mRNA CTD PMID:20044591 hydrogen peroxide increases expression ISO RGD:732751 6480464 Hydrogen Peroxide results in increased expression of NR4A1 mRNA CTD PMID:12414654 Ibotenic acid multiple interactions ISO RGD:620029 6480464 Amphetamine promotes the reaction [Ibotenic Acid results in decreased expression of NR4A1 mRNA] CTD PMID:14622910 Ibotenic acid decreases expression ISO RGD:620029 6480464 Ibotenic Acid results in decreased expression of NR4A1 mRNA CTD PMID:14622910 indole-3-methanol affects expression ISO RGD:620029 6480464 indole-3-carbinol affects the expression of NR4A1 mRNA CTD PMID:21396975 indometacin increases expression ISO RGD:732751 6480464 Indomethacin results in increased expression of NR4A1 mRNA CTD PMID:10919358 indometacin multiple interactions ISO RGD:732751 6480464 Indomethacin results in increased expression of and results in increased activity of NR4A1 protein, Tretinoin inhibits the reaction [Indomethacin results in increased expression of NR4A1 mRNA] CTD PMID:10919358 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of NR4A1 mRNA CTD PMID:20003209 kainic acid decreases expression EXP 6480464 Kainic Acid results in decreased expression of NR4A1 mRNA CTD PMID:17997037 kainic acid increases expression ISO RGD:620029 6480464 Kainic Acid results in increased expression of NR4A1 mRNA CTD PMID:19700661 kenpaullone increases expression ISO RGD:620029 6480464 kenpaullone results in increased expression of NR4A1 mRNA CTD PMID:17993264 ketorolac multiple interactions ISO RGD:620029 6480464 Ketorolac inhibits the reaction [IL1B protein results in increased expression of NR4A1 mRNA] CTD PMID:10800959 lead diacetate decreases expression ISO RGD:620029 6480464 lead acetate results in decreased expression of NR4A1 mRNA CTD PMID:22641619 leflunomide increases expression ISO RGD:732751 6480464 leflunomide results in increased expression of NR4A1 mRNA CTD PMID:28988120 leptomycin B multiple interactions ISO RGD:732751 6480464 leptomycin B inhibits the reaction [Tretinoin affects the localization of [NR4A1 protein binds to RXRA protein]] CTD PMID:14592536 linsidomine increases expression ISO RGD:620029 6480464 linsidomine results in increased expression of NR4A1 mRNA CTD PMID:10460269 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of NR4A1 mRNA CTD PMID:27339419 lipopolysaccharide increases expression ISO RGD:732751 6480464 Lipopolysaccharides results in increased expression of NR4A1 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:732751 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NR4A1 mRNA] CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:620029 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of NR4A1 mRNA CTD PMID:16415329 maneb multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] affects the expression of NR4A1 mRNA CTD PMID:22563483 menadione affects expression ISO RGD:732751 6480464 Vitamin K 3 affects the expression of NR4A1 mRNA CTD PMID:20044591 menadione increases expression ISO RGD:732751 6480464 Vitamin K 3 results in increased expression of NR4A1 mRNA CTD PMID:12414654 mercury atom decreases expression ISO RGD:620029 6480464 Mercury results in decreased expression of NR4A1 mRNA CTD PMID:12730625 mercury(0) decreases expression ISO RGD:620029 6480464 Mercury results in decreased expression of NR4A1 mRNA CTD PMID:12730625 metformin decreases expression ISO RGD:620029 6480464 Metformin results in decreased expression of NR4A1 mRNA CTD PMID:31324951 methamphetamine increases expression ISO RGD:620029 6480464 Methamphetamine results in increased expression of NR4A1 mRNA CTD PMID:15644446 methamphetamine decreases expression ISO RGD:620029 6480464 Methamphetamine results in decreased expression of NR4A1 mRNA CTD PMID:32035215 methylisothiazolinone increases expression ISO RGD:732751 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of NR4A1 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:732751 6480464 methylmercuric chloride results in increased expression of NR4A1 mRNA CTD PMID:28001369 mono(2-ethylhexyl) phthalate increases expression ISO RGD:732751 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of NR4A1 mRNA CTD PMID:19822197 mono(2-ethylhexyl) phthalate decreases expression ISO RGD:732751 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of NR4A1 mRNA CTD PMID:23118965 mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of NR4A1 mRNA CTD PMID:22401849 morphine increases expression EXP 6480464 Morphine results in increased expression of NR4A1 mRNA CTD PMID:21955143 Muraglitazar decreases expression ISO RGD:620029 6480464 muraglitazar results in decreased expression of NR4A1 mRNA CTD PMID:21515302 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions EXP 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [bisphenol A results in increased expression of NR4A1 mRNA] CTD PMID:12021184 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:732751 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [cadmium acetate results in increased expression of NR4A1 protein] CTD PMID:15016657 N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanecarboxamide increases expression ISO RGD:620029 6480464 N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide results in increased expression of NR4A1 mRNA CTD PMID:19695244 N-methyl-4-phenylpyridinium increases expression ISO RGD:732751 6480464 1-Methyl-4-phenylpyridinium results in increased expression of NR4A1 mRNA CTD PMID:24810058 N-nitrosodimethylamine increases expression ISO RGD:620029 6480464 Dimethylnitrosamine results in increased expression of NR4A1 mRNA CTD PMID:17032414 N-Nitrosopyrrolidine increases expression ISO RGD:732751 6480464 N-Nitrosopyrrolidine results in increased expression of NR4A1 mRNA CTD PMID:32234424 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions ISO RGD:620029 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of NR4A1 mRNA CTD PMID:16415329 naphthalenes increases expression ISO RGD:620029 6480464 Naphthalenes results in increased expression of NR4A1 protein CTD PMID:17337753 nickel atom increases expression EXP 6480464 Nickel results in increased expression of NR4A1 mRNA CTD PMID:12540486 nickel sulfate increases expression ISO RGD:732751 6480464 nickel sulfate results in increased expression of NR4A1 mRNA CTD PMID:16780908 nicotinamide multiple interactions EXP 6480464 [Glycerol co-treated with Succinic Acid co-treated with Glucose-6-Phosphate co-treated with Pantothenic Acid co-treated with Niacinamide] results in increased expression of NR4A1 mRNA CTD PMID:20505214 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of NR4A1 mRNA CTD PMID:21955143 nicotine increases expression EXP 6480464 Nicotine results in increased expression of NR4A1 mRNA CTD PMID:17456735 nitric oxide increases expression ISO RGD:620029 6480464 Nitric Oxide results in increased expression of NR4A1 mRNA CTD PMID:10460269 oxaliplatin multiple interactions ISO RGD:620029 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NR4A1 mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:620029 6480464 oxaliplatin results in increased expression of NR4A1 mRNA CTD PMID:25729387 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of NR4A1 mRNA, pyrazolanthrone promotes the reaction [Ozone results in increased expression of NR4A1 mRNA] CTD PMID:17460151 , PMID:34911549 ozone multiple interactions ISO RGD:732751 6480464 [[Ozone results in increased oxidation of dimethylselenide] which results in increased expression of NR4A1AS mRNA] which results in increased expression of NR4A1 mRNA CTD PMID:33656867 ozone increases expression ISO RGD:620029 6480464 Ozone results in increased expression of NR4A1 mRNA CTD PMID:16716893 ozone multiple interactions ISO RGD:620029 6480464 [Ozone co-treated with Chlorine] affects the expression of NR4A1 mRNA CTD PMID:18636392 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of NR4A1 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:620029 6480464 Acetaminophen results in increased expression of NR4A1 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:732751 6480464 Acetaminophen results in increased expression of NR4A1 mRNA CTD PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of NR4A1 mRNA CTD PMID:11264010 paraquat increases expression EXP 6480464 Paraquat results in increased expression of NR4A1 mRNA CTD PMID:12595580 paraquat multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] affects the expression of NR4A1 mRNA CTD PMID:22563483 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of NR4A1 mRNA CTD PMID:21463325 , PMID:22563483 paricalcitol multiple interactions ISO RGD:732751 6480464 [Phosphorus co-treated with paricalcitol] affects the expression of NR4A1 mRNA CTD PMID:17715259 pentetrazol multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [Pentylenetetrazole results in increased expression of NR4A1 mRNA] CTD PMID:8164692 pentetrazol increases expression EXP 6480464 Pentylenetetrazole results in increased expression of NR4A1 mRNA CTD PMID:8164692 pentobarbital multiple interactions ISO RGD:620029 6480464 Chorionic Gonadotropin inhibits the reaction [Pentobarbital results in decreased expression of NR4A1 mRNA] CTD PMID:11416027 pentobarbital decreases expression ISO RGD:620029 6480464 Pentobarbital results in decreased expression of NR4A1 mRNA CTD PMID:11416027 perfluorooctanoic acid decreases expression ISO RGD:620029 6480464 perfluorooctanoic acid results in decreased expression of NR4A1 mRNA CTD PMID:19162173 phenformin decreases expression ISO RGD:620029 6480464 Phenformin results in decreased expression of NR4A1 mRNA CTD PMID:31324951 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of NR4A1 mRNA CTD PMID:19270015 phorbol 13-acetate 12-myristate affects localization ISO RGD:732751 6480464 Tetradecanoylphorbol Acetate affects the localization of NR4A1 protein CTD PMID:12376465 , PMID:28754437 phorbol 13-acetate 12-myristate increases expression EXP 6480464 Tetradecanoylphorbol Acetate results in increased expression of NR4A1 protein CTD PMID:18787026 , PMID:19282384 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NR4A1 protein] more ... CTD PMID:18787026 , PMID:19282384 phorbol 13-acetate 12-myristate increases expression ISO RGD:732751 6480464 Tetradecanoylphorbol Acetate results in increased expression of NR4A1 mRNA CTD PMID:12376465 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:732751 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NR4A1 mRNA CTD PMID:16979875 phosphorus atom multiple interactions ISO RGD:732751 6480464 [Phosphorus co-treated with paricalcitol] affects the expression of NR4A1 mRNA CTD PMID:17715259 phosphorus(.) multiple interactions ISO RGD:732751 6480464 [Phosphorus co-treated with paricalcitol] affects the expression of NR4A1 mRNA CTD PMID:17715259 pioglitazone increases expression EXP 6480464 pioglitazone results in increased expression of NR4A1 mRNA CTD PMID:17785466 potassium atom increases expression ISO RGD:620029 6480464 Potassium results in increased expression of NR4A1 mRNA CTD PMID:10693946 potassium chloride multiple interactions ISO RGD:732751 6480464 Dronabinol inhibits the reaction [Potassium Chloride results in increased expression of NR4A1 mRNA] CTD PMID:29691375 potassium chloride increases expression ISO RGD:732751 6480464 Potassium Chloride results in increased expression of NR4A1 mRNA CTD PMID:29691375 potassium chromate multiple interactions ISO RGD:732751 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of NR4A1 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:732751 6480464 potassium chromate(VI) results in increased expression of NR4A1 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:620029 6480464 Pregnenolone Carbonitrile results in increased expression of NR4A1 mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of NR4A1 mRNA CTD PMID:22698814 proanthocyanidin multiple interactions ISO RGD:732751 6480464 Proanthocyanidins inhibits the reaction [quinocetone metabolite affects the expression of NR4A1 mRNA] CTD PMID:26802905 progesterone increases expression ISO RGD:732751 6480464 Progesterone results in increased expression of NR4A1 mRNA CTD PMID:18037150 progesterone multiple interactions EXP 6480464 NR4A1 protein mutant form inhibits the reaction [bisphenol A results in increased abundance of Progesterone] more ... CTD PMID:12021184 , PMID:18525235 pyridaben decreases expression EXP 6480464 pyridaben results in decreased expression of NR4A1 mRNA CTD PMID:22563483 quercetin increases expression ISO RGD:732751 6480464 Quercetin results in increased expression of NR4A1 mRNA CTD PMID:21632981 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of NR4A1 mRNA CTD PMID:25862958 rac-lactic acid increases expression ISO RGD:732751 6480464 Lactic Acid results in increased expression of NR4A1 mRNA CTD PMID:30851411 raloxifene increases expression ISO RGD:732751 6480464 Raloxifene Hydrochloride results in increased expression of NR4A1 mRNA CTD PMID:16514628 ranitidine multiple interactions ISO RGD:620029 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of NR4A1 mRNA CTD PMID:16415329 reactive oxygen species affects expression ISO RGD:732751 6480464 Reactive Oxygen Species affects the expression of NR4A1 mRNA CTD PMID:25800948 Rebamipide increases expression ISO RGD:620029 6480464 rebamipide results in increased expression of NR4A1 mRNA CTD PMID:15104358 rotenone decreases expression ISO RGD:620029 6480464 Rotenone results in decreased expression of NR4A1 mRNA CTD PMID:28374803 ryanodine multiple interactions EXP 6480464 NR4A1 protein inhibits the reaction [Ryanodine inhibits the reaction [Colforsin results in increased expression of STAR protein]] more ... CTD PMID:23183170 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:732751 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NR4A1 mRNA] CTD PMID:35811015 SB 203580 multiple interactions EXP 6480464 SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of NR4A1 mRNA] CTD PMID:28329830 scopolamine decreases expression ISO RGD:620029 6480464 Scopolamine results in decreased expression of NR4A1 mRNA CTD PMID:17540011 sevoflurane affects expression ISO RGD:620029 6480464 sevoflurane affects the expression of NR4A1 mRNA CTD PMID:15967596 Shikonin multiple interactions EXP 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of NR4A1 mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A1 mRNA] CTD PMID:25451590 silicon dioxide increases expression ISO RGD:732751 6480464 Silicon Dioxide analog results in increased expression of NR4A1 mRNA CTD PMID:23806026 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of NR4A1 mRNA CTD PMID:29341224 silicon dioxide decreases expression ISO RGD:620029 6480464 Silicon Dioxide results in decreased expression of NR4A1 mRNA CTD PMID:32721576 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of NR4A1 mRNA CTD PMID:19073995 more ... silver atom increases expression ISO RGD:732751 6480464 Silver results in increased expression of NR4A1 mRNA CTD PMID:26014281 , PMID:28959546 silver atom increases expression EXP 6480464 Silver results in increased expression of NR4A1 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:732751 6480464 Silver results in increased expression of NR4A1 mRNA CTD PMID:26014281 , PMID:28959546 silver(0) increases expression EXP 6480464 Silver results in increased expression of NR4A1 mRNA CTD PMID:27131904 sodium arsenate decreases expression EXP 6480464 sodium arsenate results in decreased expression of NR4A1 mRNA CTD PMID:21795629 sodium arsenite increases expression ISO RGD:732751 6480464 sodium arsenite results in increased expression of NR4A1 mRNA CTD PMID:12760830 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of NR4A1 mRNA, sodium arsenite results in increased expression of NR4A1 protein CTD PMID:16014739 , PMID:17682005 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of NR4A1 mRNA CTD PMID:27859739 Soman increases expression ISO RGD:620029 6480464 Soman results in increased expression of NR4A1 mRNA CTD PMID:19281266 styrene affects expression EXP 6480464 Styrene affects the expression of NR4A1 mRNA CTD PMID:28951217 succinic acid multiple interactions EXP 6480464 [Glycerol co-treated with Succinic Acid co-treated with Glucose-6-Phosphate co-treated with Pantothenic Acid co-treated with Niacinamide] results in increased expression of NR4A1 mRNA CTD PMID:20505214 sulforaphane increases expression EXP 6480464 sulforaphane results in increased expression of NR4A1 mRNA CTD PMID:30529165 T-2 toxin decreases expression ISO RGD:732751 6480464 T-2 Toxin results in decreased expression of NR4A1 mRNA CTD PMID:31863870 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of NR4A1 mRNA CTD PMID:17555576 terbufos increases expression ISO RGD:732751 6480464 terbufos results in increased expression of NR4A1 CTD PMID:21538558 tert-butyl hydroperoxide increases expression ISO RGD:732751 6480464 tert-Butylhydroperoxide results in increased expression of NR4A1 mRNA CTD PMID:12414654 testosterone multiple interactions ISO RGD:732751 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of NR4A1 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:732751 6480464 Testosterone results in increased expression of NR4A1 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:620029 6480464 Carbon Tetrachloride results in increased expression of NR4A1 mRNA CTD PMID:17032414 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of NR4A1 mRNA CTD PMID:31919559 thalidomide increases expression ISO RGD:732751 6480464 Thalidomide analog results in increased expression of NR4A1 mRNA CTD PMID:20525221 thimerosal increases expression ISO RGD:732751 6480464 Thimerosal results in increased expression of NR4A1 mRNA CTD PMID:16870260 thioacetamide increases expression ISO RGD:620029 6480464 Thioacetamide results in increased expression of NR4A1 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of NR4A1 mRNA CTD PMID:27760801 titanium dioxide decreases expression ISO RGD:620029 6480464 titanium dioxide results in decreased expression of NR4A1 mRNA CTD PMID:30012374 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of NR4A1 mRNA CTD PMID:23557971 topotecan multiple interactions ISO RGD:620029 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NR4A1 mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:732751 6480464 torcetrapib results in increased expression of NR4A1 mRNA CTD PMID:19164467 , PMID:23228038 triazolam decreases expression EXP 6480464 Triazolam results in decreased expression of NR4A1 mRNA CTD PMID:27489535 tributylstannane decreases expression EXP 6480464 tributyltin results in decreased expression of NR4A1 mRNA CTD PMID:30027469 Tributyltin oxide increases expression ISO RGD:620029 6480464 bis(tri-n-butyltin)oxide results in increased expression of NR4A1 mRNA CTD PMID:17553608 Tributyltin oxide increases expression ISO RGD:732751 6480464 bis(tri-n-butyltin)oxide results in increased expression of NR4A1 mRNA, bis(tri-n-butyltin)oxide results in increased expression of NR4A1 protein CTD PMID:21601586 more ... trichloroethene increases expression ISO RGD:620029 6480464 Trichloroethylene results in increased expression of NR4A1 mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO RGD:732751 6480464 [Fenretinide co-treated with trichostatin A] affects the localization of NR4A1 protein more ... CTD PMID:21319187 trichostatin A increases expression ISO RGD:732751 6480464 trichostatin A results in increased expression of NR4A1 mRNA, trichostatin A results in increased expression of NR4A1 protein CTD PMID:21319187 trichostatin A affects localization ISO RGD:732751 6480464 trichostatin A affects the localization of NR4A1 protein CTD PMID:21319187 triphenylstannane decreases expression ISO RGD:620029 6480464 triphenyltin results in decreased expression of NR4A1 mRNA, triphenyltin results in decreased expression of NR4A1 protein CTD PMID:32504733 tris(2-butoxyethyl) phosphate affects expression ISO RGD:732751 6480464 tris(2-butoxyethyl) phosphate affects the expression of NR4A1 mRNA CTD PMID:29024780 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of NR4A1 mRNA CTD PMID:17785466 troglitazone decreases expression ISO RGD:620029 6480464 troglitazone results in decreased expression of NR4A1 mRNA CTD PMID:21515302 trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of NR4A1 mRNA CTD PMID:35537566 undecane increases expression ISO RGD:620029 6480464 undecane results in increased expression of NR4A1 protein CTD PMID:17337753 urethane increases expression ISO RGD:732751 6480464 Urethane results in increased expression of NR4A1 mRNA CTD PMID:28818685 vinclozolin affects expression ISO RGD:620029 6480464 vinclozolin affects the expression of NR4A1 mRNA CTD PMID:19015723 zearalenone multiple interactions EXP 6480464 Colforsin promotes the reaction [Zearalenone results in increased expression of NR4A1 mRNA] CTD PMID:26783879 zearalenone decreases expression EXP 6480464 Zearalenone results in decreased expression of NR4A1 protein CTD PMID:24512812 zearalenone increases expression EXP 6480464 Zearalenone results in increased expression of NR4A1 mRNA CTD PMID:26783879 zinc atom multiple interactions ISO RGD:732751 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of NR4A1 mRNA, [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NR4A1 mRNA CTD PMID:16979875 , PMID:18593933 zinc atom increases expression ISO RGD:732751 6480464 Zinc deficiency results in increased expression of NR4A1 mRNA CTD PMID:18356318 zinc(0) multiple interactions ISO RGD:732751 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of NR4A1 mRNA, [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NR4A1 mRNA CTD PMID:16979875 , PMID:18593933 zinc(0) increases expression ISO RGD:732751 6480464 Zinc deficiency results in increased expression of NR4A1 mRNA CTD PMID:18356318
